Effect of ACTH and Metyrapone on Estriol, 17-Hydroxycorticosteroid, 17-Ketosteroid, Pregnanediol and Pregnanetriol Excretion Late in Pregnancy
Richard Palmer Dickey, James P. Thompson
Abstract
Richard Palmer Dickey, James P. Thompson
Abstract
The effect of ACTH and metyrapone administration on excretion of estriol, 17- hydroxycorticosteroid (17-OHCS), 17-ketosteroid (17-KS), pregnanediol (P-diol) and pregnanetriol (P-triol) was determined in 16 women in the last trimester of pregnancy. The response to ACTH and metyrapone, measured as 17- OHCS excretion, was diminished compared to that reported for nonpregnant women, but was approximately the same when either agent was given. This suggests that altered ACTH release is not the cause of this diminished response. Estriol excretion decreased significantly (p <.00l) following ACTH and increased (p<.1) in 10 of 16 following metyrapone. 17-KS and P-triol changes corresponded to those found for estriol rather than to those found for 17-OHCS. This finding suggests that cortisol from the maternal adrenal may inhibit the fetal pituitaryadrenal axis during pregnancy.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of ACTH and metyrapone administration on excretion of estriol, 17- hydroxycorticosteroid (17-OHCS), 17-ketosteroid (17-KS), pregnanediol (P-diol) and pregnanetriol (P-triol) was determined in 16 women in the last trimester of pregnancy. The response to ACTH and metyrapone, measured as 17- OHCS excretion, was diminished compared to that reported for nonpregnant women, but was approximately the same when either agent was given. This suggests that altered ACTH release is not the cause of this diminished response. Estriol excretion decreased significantly (p <.00l) following ACTH and increased (p<.1) in 10 of 16 following metyrapone. 17-KS and P-triol changes corresponded to those found for estriol rather than to those found for 17-OHCS. This finding suggests that cortisol from the maternal adrenal may inhibit the fetal pituitaryadrenal axis during pregnancy.
Key concepts: Pregnanediol, Metyrapone, Estriol, Endocrinology, Internal medicine, Excretion, Pregnancy, Adrenocorticotropic hormone